date,title,source
Oct-25-18,"Recent Analysis Shows PennyMac Mortgage Investment Trust, Amicus Therapeutics, Children's Place, PLDT, NanoString Technologies, and Worthington Industries Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-29-18,Today's Research Reports on Trending Tickers: Amicus Therapeutics and Geron,ACCESSWIRE
Oct-29-18,"Amicus Therapeutics to Announce Third Quarter 2018 Financial Results on November 5, 2018",GlobeNewswire
Nov-05-18,Edited Transcript of FOLD earnings conference call or presentation 5-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-05-18,"Amicus Therapeutics (FOLD) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-05-18,Amicus Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-05-18,Amicus Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Updates,GlobeNewswire
Nov-12-18,Amicus Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference,GlobeNewswire
Nov-14-18,Today's Research Reports on Trending Tickers: Amicus Therapeutics and FibroGen,ACCESSWIRE
Nov-19-18,Edited Transcript of FOLD earnings conference call or presentation 5-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-20-18,Edited Transcript of FOLD earnings conference call or presentation 5-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-29-18,Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and Amicus Therapeutics,ACCESSWIRE
Dec-04-18,"Consolidated Research: 2018 Summary Expectations for Xencor, Cyclacel Pharmaceuticals, Amicus Therapeutics, Take-Two Interactive Software, CSG Systems International, and Vonage  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Dec-10-18,"Amicus Therapeutics, Inc. (FOLD) Hedge Funds Are Snapping Up",Insider Monkey
Dec-12-18,"Should You Worry About Amicus Therapeutics, Inc.s (NASDAQ:FOLD) CEO Pay?",Simply Wall St.
Dec-19-18,Amicus Therapeutics Announces Executive Team Updates,GlobeNewswire
Dec-20-18,Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease,GlobeNewswire
Jan-03-19,Amicus Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-03-19,Amicus Therapeutics Announces Phase 1/2 Study of Gene Therapy for CLN3 Batten Disease,GlobeNewswire
Jan-07-19,Amicus Therapeutics Provides Full-Year 2019 Strategic Outlook and Financial Guidance,GlobeNewswire
